DISCLAIM IT: Hud is in no way a financial advisor, nor am I suggesting anybody do anything with their monies. I'm just simply reporting what I see as I see
I've been new to the trading game because I just never had my priorities straight. now that I do I'm pushing a bit into ABCL as its rated “buy” from whomever it is to make such decisions. Also reading from *link* https://www.americanbankingnews.com/2023/06/22/abcellera-biologics-nasdaqabcl-sees-unusually-high-trading-volume.html *link* it says that 32.45% of the companies stock is owned by insiders, another 49ish% is owned by institutional investors. I'm not sure if that means these are the MF to follow, but I've been on this if you cant beat em join em kind of kick and i got a decent feeling this is one of them situations. Especially seeing as to how their CEO bought 2.3m's worth @ $11.46 in the past 12 mo, with their avg share purchase price being a lil over $9. Plus no sign of anyone selling them yet either (for obvious reasons rn) IDK bout yall but I feel like this is one to not miss
Leave a Reply